logo

Galapagos Nv.. (GLPG)



Trade GLPG now with
  Date
  Headline
10/12/2020 9:19:35 AM Gilead:Phase 2b/3 Trial Shows Efficacy Of Filgotinib For Maintenance Of Remission In Moderately And Severely Active UC
9/25/2020 1:04:00 PM European Commission Grants Marketing Authorization For Jyseleca For Treatment Of Rheumatoid Arthritis
9/10/2020 11:19:21 PM Galapagos Says Primary Endpoint Achieved With Ziritaxestat In NOVESA Trial In Systemic Sclerosis Patients
8/19/2020 10:03:24 AM Stock Alert: Galapagos Tanks 25%
8/19/2020 12:36:48 AM Galapagos: Gilead Sciences Receives CRL From FDA For NDA For Filgotinib
7/24/2020 8:12:41 AM Gilead And Galapagos Announce Positive European CHMP Opinion For Jyseleca For Moderate To Severe Rheumatoid Arthritis
6/4/2020 1:07:03 AM Gilead Sciences, Galapagos Announce 52-week Results From Phase 3 FINCH 1 And FINCH 3 Studies Of Filgotinib